{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:13:52Z","timestamp":1760055232127,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.gcb.2008.10.009","type":"journal-article","created":{"date-parts":[[2008,12,14]],"date-time":"2008-12-14T04:38:28Z","timestamp":1229229508000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Is physical activity possible and beneficial for patients with hepatitis C receiving pegylated interferon and ribavarin therapy?"],"prefix":"10.1016","volume":"33","author":[{"given":"J.-L.","family":"Payen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mascarell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Couzigou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kharlov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gcb.2008.10.009_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0399-8320(08)73268-8","article-title":"Prise en charge de l\u2019h\u00e9patite C en 2008","volume":"32","author":"Pol","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gcb.2008.10.009_bib2","unstructured":"SOS H\u00e9patites. Vivre avec une h\u00e9patite virale. www.actif-sante.org\/html\/docs\/enquete_soshepatite.pps. (visited on 27 November 2008)."},{"key":"10.1016\/j.gcb.2008.10.009_bib3","first-page":"B257","article-title":"Qualit\u00e9 de vie des personnes malades atteintes d\u2019h\u00e9patite chronique virale C: effets des traitements","volume":"26","author":"Couzigou","year":"2002","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gcb.2008.10.009_bib4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1440-1746.2003.03216.x","article-title":"Quality of life of women living with hepatitis C","volume":"18","author":"Thein","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gcb.2008.10.009_bib5","first-page":"1084","article-title":"\u00c9valuation de la qualit\u00e9 de vie au cours de l\u2019h\u00e9patite chronique C, influence du traitement","volume":"27","author":"Desmorat","year":"2003","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gcb.2008.10.009_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.510300504","article-title":"The impact of diagnosis of hepatitis C virus on quality of life","volume":"30","author":"Rodger","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2008.10.009_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.20014","article-title":"Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection","volume":"39","author":"Dalgard","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2008.10.009_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.20659","article-title":"Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment","volume":"41","author":"Spiegel","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2008.10.009_bib9","series-title":"H\u00e9patite C","first-page":"273","article-title":"Qualit\u00e9 de vie des personnes infect\u00e9es par le virus de l\u2019h\u00e9patite C","author":"Couzigou","year":"2004"},{"key":"10.1016\/j.gcb.2008.10.009_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2006.05.016","article-title":"Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment","volume":"131","author":"S\u00e1nchez-Tapias","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2008.10.009_bib11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jhep.2007.07.015","article-title":"Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the \u2018accordion\u2019 regimen?","volume":"47","author":"Marcellin","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.gcb.2008.10.009_bib12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gcb.2008.10.009_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gcb.2008.10.009_bib14","article-title":"Chronic hepatitis C: management of side effects of treatment","volume":"31","author":"Larrey","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gcb.2008.10.009_bib15","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","article-title":"Randomised trial of interferon alpha 2b plus ribavirin for 48 weeks or 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus","volume":"352","author":"Poynard","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2008.10.009_bib16","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chrnoic hepatitis C","volume":"122","author":"Poynard","year":"2002","journal-title":"Gastroenterology"},{"year":"1998","series-title":"Le consentement, information, autonomie et d\u00e9cision en m\u00e9decine","author":"Hoerni","key":"10.1016\/j.gcb.2008.10.009_bib17"},{"key":"10.1016\/j.gcb.2008.10.009_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hep.22044","article-title":"Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial","volume":"47","author":"Seeff","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2008.10.009_bib19","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/hep.510280631","article-title":"Better efficacy of 12-month interferon alpha 2B retreatment in patient with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial","volume":"28","author":"Payen","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2008.10.009_bib20","article-title":"Traitement des maladies de longue dur\u00e9e\u00a0: de la phase aigu\u00eb au stade de la chronicit\u00e9. Une autre gestion de la maladie, un autre processus de la prise en charge","author":"Assal","year":"1996","journal-title":"Encycl Med Chir"},{"key":"10.1016\/j.gcb.2008.10.009_bib21","first-page":"2285","article-title":"Compliance et hypertension art\u00e9rielle\u00a0: comment aider les patients \u00e0 suivre le traitement prescript\u00a0?","volume":"51","author":"Humair","year":"1993","journal-title":"Med Hyg"},{"key":"10.1016\/j.gcb.2008.10.009_bib22","first-page":"3","article-title":"\u00c9ducation th\u00e9rapeutique du patient","volume":"404","author":"Gagnayren","year":"1998","journal-title":"Impact Medecin Hebdo"},{"key":"10.1016\/j.gcb.2008.10.009_bib23","first-page":"12","article-title":"Quelles pratiques et comp\u00e9tences en \u00e9ducation du patient\u00a0? Recommandations de l\u2019organisation mondiale de la sant\u00e9 (r\u00e9gion Europe)","volume":"341","author":"Deccache","year":"1999","journal-title":"La sant\u00e9 de l\u2019homme"},{"year":"1995","series-title":"Apprendre \u00e0 \u00e9duquer le patient","author":"D\u2019Ivernois","key":"10.1016\/j.gcb.2008.10.009_bib24"},{"key":"10.1016\/j.gcb.2008.10.009_bib25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1086\/338402","article-title":"Reduction of abdominal obesity in lipodystrophy associated with human immunodeficiency virus infection by means of diet and exercise: case report and proof of principle","volume":"34","author":"Roubenoff","year":"2002","journal-title":"CID"},{"key":"10.1016\/j.gcb.2008.10.009_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1521-6942(03)00038-X","article-title":"Physical exercise in fibromyalgia and related syndromes","volume":"17","author":"Mannerkorpi","year":"2003","journal-title":"Brest Pract Res Clin Rheumatol"},{"key":"10.1016\/j.gcb.2008.10.009_bib27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1590\/S0066-782X2002001300003","article-title":"Benefits of exercise training in the treatment of heart failure: study with a control group","volume":"79","author":"Silva","year":"2002","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.gcb.2008.10.009_bib28","first-page":"627","article-title":"Physical activity for chronically ill and disabled","volume":"31","author":"Durstine","year":"2001","journal-title":"Sports Med"},{"key":"10.1016\/j.gcb.2008.10.009_bib29","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/jama.288.13.1622","article-title":"Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health","volume":"288","author":"Stewart","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.gcb.2008.10.009_bib30","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2007.02.055","article-title":"A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed","volume":"49","author":"Haykowsky","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.gcb.2008.10.009_bib31","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1136\/gut.2006.112094","article-title":"Benefits of lifestyle modification in NAFLD","volume":"56","author":"Harrison","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2008.10.009_bib32","first-page":"S39","article-title":"Weight loss as a treatment for nonalcoholic fatty liver disease","volume":"40","author":"Clark","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gcb.2008.10.009_bib33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.21262","article-title":"NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice","volume":"44","author":"Nobili","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2008.10.009_bib34","first-page":"CD004248","article-title":"Progressive resistive exercise interventions for adults living with HIV\/AIDS","author":"O\u2019Brien","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gcb.2008.10.009_bib35","first-page":"CD003331","article-title":"Exercise based rehabilitation for heart failure","author":"Rees","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gcb.2008.10.009_bib36","first-page":"CD003980","article-title":"Exercise therapy for multiple sclerosis","author":"Rietberg","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gcb.2008.10.009_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1388-9842(00)00087-8","article-title":"Comprehensive localm muscle training increases aerobic working capacity and quality of life and decreasese neurohormonal activation in patients with chronic heart failure","volume":"3","author":"Tyni-Lenn\u00e9","year":"2001","journal-title":"Eur H Heart Fail"},{"key":"10.1016\/j.gcb.2008.10.009_bib38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36)","volume":"30","author":"Wade","year":"1992","journal-title":"Medical Care"},{"key":"10.1016\/j.gcb.2008.10.009_bib39","first-page":"1357","article-title":"\u00c9laboration d\u2019un dossier d\u2019examen de non-contre-indication aux activit\u00e9s physiques et sportives","volume":"670-71","author":"Buchet","year":"2004","journal-title":"Rev Prat"},{"key":"10.1016\/j.gcb.2008.10.009_bib40","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1152\/jappl.1986.60.6.2020","article-title":"A new method for detecting anaerobic threshold by gas exchange","volume":"60","author":"Beaver","year":"1986","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.gcb.2008.10.009_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5271\/sjweh.1815","article-title":"Psychophysical scaling with applications in physical work and the perception of exertion","volume":"16","author":"Borg","year":"1990","journal-title":"Scand J Work Environ Health"},{"key":"10.1016\/j.gcb.2008.10.009_bib42","first-page":"42","article-title":"Effect of bicycle ergometry traineing program in the acute phase of viral hepatitis on its late prognosis","volume":"38","author":"Metzner","year":"1983","journal-title":"Z Gesamte Inn Med"},{"key":"10.1016\/j.gcb.2008.10.009_bib43","first-page":"511A","article-title":"An exercice intervention to prevent hepatitis-related fatigue (abstract)","volume":"40","author":"Zucker","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2008.10.009_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1472-6963-7-36","article-title":"Exercise on prescription: trial protocol and evaluation of outcomes","volume":"7","author":"S\u00f8rensen","year":"2007","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.gcb.2008.10.009_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/pubmed\/fdh197","article-title":"Does primary care referral to an exercise programme increase physical activity one year later? A randomized controlled trial","volume":"27","author":"Harrison","year":"2005","journal-title":"J Public Health (Oxf)"},{"key":"10.1016\/j.gcb.2008.10.009_bib46","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/00001610-200505001-00003","article-title":"Factors influencing the development of a hepatitis C exercise protocol: a literature review","volume":"28","author":"Gapinski","year":"2005","journal-title":"Gastroenterol Nurs"}],"container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832008005964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832008005964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:47:06Z","timestamp":1759974426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399832008005964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0399832008005964"],"URL":"https:\/\/doi.org\/10.1016\/j.gcb.2008.10.009","relation":{},"ISSN":["0399-8320"],"issn-type":[{"type":"print","value":"0399-8320"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is physical activity possible and beneficial for patients with hepatitis C receiving pegylated interferon and ribavarin therapy?","name":"articletitle","label":"Article Title"},{"value":"Gastroent\u00e9rologie Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gcb.2008.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}